MarketCap
Facebook
X
Telegram
Curis Operating Cycle | CRIS
Annual Operating Cycle Curis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.7 | 103 | 105 | 111 | 107 | 106 | 118 | 100 | 113 | 119 | 97.6 | 72.7 | 35.9 | 19.5 | - | 1.05 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 119 | 1.05 | 85 |
Quarterly Operating Cycle Curis
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 86.1 | 84.1 | 109 | - | 86 | 84.2 | 108 | - | 84.3 | 97.6 | 105 | - | 46.6 | 39.3 | 117 | - | 80.1 | 91 | 109 | 91.8 | 101 | 118 | 106 | 90.1 | 104 | 141 | 158 | 94.9 | 91.8 | 111 | 110 | 86 | 115 | 136 | 118 | 95 | 128 | 134 | 121 | 91.9 | 94 | 92.3 | 112 | 89.8 | 101 | 37.3 | 122 | 88.4 | 18.7 | 24.9 | 125 | 49.1 | 143 | 19 | 4.19 | 0.27 | 26.1 | 9.77 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 158 | 0.27 | 89.4 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Seer
SEER
|
343 | $ 1.63 | 0.18 % | $ 90.4 M |  USA |
 |
Stoke Therapeutics
STOK
|
7.52 | $ 26.51 | 1.69 % | $ 1.57 B | USA |
 |
Sutro Biopharma
STRO
|
22.4 | $ 9.57 | 4.08 % | $ 81.3 M | USA |
 |
Soligenix
SNGX
|
87.4 | $ 0.34 | 0.54 % | $ 1.76 M | USA |
 |
Supernus Pharmaceuticals
SUPN
|
492 | $ 26.14 | -2.24 % | $ 1.48 B | USA |
 |
Galapagos NV
GLPG
|
149 | - | - | $ 1.83 B |  Belgium |
 |
Teligent, Inc.
TLGT
|
167 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
174 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
556 | $ 59.78 | 3.1 % | $ 8.63 B | USA |
 |
Aphria Inc.
APHA
|
156 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Chiasma, Inc.
CHMA
|
19.9 | - | -6.00 % | $ 238 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 3.37 | 4.66 % | $ 568 M |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
252 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
82.8 | - | 0.38 % | $ 12.9 M |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
53.4 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
25.6 | - | -1.68 % | $ 283 M | USA |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
138 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
52.8 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
71.9 | - | - | $ 6.81 B |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
47 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
2.11 K | - | - | $ 256 M | Canada |
 |
XBiotech
XBIT
|
40.8 | $ 1.88 | 0.53 % | $ 57.3 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
820 | - | -2.54 % | $ 57.2 M | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
67.9 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
0.969 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
124 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
176 | - | - | $ 1.77 B | USA |
 |
Translate Bio, Inc.
TBIO
|
53.1 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
295 | - | - | $ 1.94 B | Canada |
 |
Exicure
XCUR
|
-4.16 | $ 0.91 | 2.77 % | $ 5.73 M | USA |
 |
Urovant Sciences Ltd.
UROV
|
65.2 | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
410 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
75.3 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
5.04 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
5.04 | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
63.5 | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
35.8 | $ 39.02 | 3.56 % | $ 3.09 B | Canada |